The BTG1 gene, mutated exclusively in two responders with a CR in this analysis, was previously characterized as a negative regulator of cell cycle progression and cell proliferation,34 and mutations in this gene were enriched in human B‐cell precursor acute lymphoblastic leukemia and were associated with inferior outcomes.35 Here, BTG1 is linked to acute lymphoblastic leukemia.